WTW Willis Towers Watson Public Limited Company

Geopolitics, trade rules, and energy regulation are colliding to reshape how risk is priced, insured, and transferred. That mix creates potential openings for investors who understand which stocks are most exposed to these headlines, and which might benefit from demand for trade-disruption insurance and risk management. This article walks through three stocks from our Global Trade-Disruption Insurance and Risk Management Stocks screener that are closely tied to the current news flow. The...

WTW (NASDAQ:WTW) has partnered with Softtek to combine workforce strategy and organizational change expertise with AI engineering and implementation capabilities, targeting companies seeking to move AI transformation plans into operational deployment. Key Investor TakeawaysWTW and Softtek have formed a strategic AI partnership focused on enterprise AI workforce transformation.

Willis Towers Watson Plc (NASDAQ:WTW), a global risk and advisory firm, expanded its relationship with Zurich Insurance Company Limited (OTC:ZURVY) through a global agreement to deploy its Radar pricing and analytics platform across Zurich’s target Retail markets worldwide. WTW shares rose in Monday’s premarket session following the announcement. Financial terms of the expanded agreement were not disclosed. WTW Expands Radar Partnership With Zurich The rollout extends Radar beyond the country-le

The deal builds on an existing partnership between the two companies.

Warren Buffett's step back from Berkshire forces a harder question: which public companies actually run his playbook, and how close do any of them get to the real thing?

Geopolitical risk in the Middle East has moved from background noise to headline driver, with Iran, the Strait of Hormuz and Houthi attacks all reshaping how capital views global shipping and war-related exposure. Investors now face a rare moment where insurance-linked stocks tied to these routes could see their risk, pricing power and demand profile change at the same time. This article walks through 3 stocks from our Global Marine Insurance and War-Risk Insurers screener that appear most...

Willis Towers Watson has delivered a 51.3% share price gain over the past three years, yet more recent returns have cooled, which puts a spotlight on whether the business is earning enough on its capital to back up today’s valuation. With the stock now trading at around US$312.91, investors are increasingly focused on how the company’s economics line up with the current price tag. That 51.3% rise over three years raises a clear question about whether Willis Towers Watson’s current market...

Brown & Brown's fee growth, acquisitions and strong cash flow support expansion, while rising expenses and interest costs pressure margins.

Willis Towers Watson's organic growth, AI investments and acquisitions support expansion, while softer insurance rates and competition pose risks.

Not every dividend survives a rough macro quarter, but some payouts are structured to keep growing no matter what the economy does. Five Nasdaq stocks built on contracted fees, recurring subscriptions, and regulated rates are making a case for income investors heading into year end.

Even though Willis Towers Watson has lagged behind the financial service sector over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Was it legal for the WTW employees to leave en masse — or for their competitor, Lockton, to recruit them?

WTW, AJG and AON are finding new growth drivers as insurance pricing fades, with organic growth fueled by volume, retention and share gains.

Even though Willis Towers Watson has lagged behind the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Willis Towers Watson (WTW) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Willis Towers Watson (WTW) recently appointed Jayne Bok as Head of Hong Kong and Macau, while she continues as Head of Investments, Asia. This leadership change gives investors fresh context for thinking about the stock. See our latest analysis for Willis Towers Watson. Against this leadership backdrop, Willis Towers Watson’s short term momentum has cooled, with a 7 day share price return of 4.23%. However, the 90 day share price return of 29.07% and 3 year total shareholder return of 69.89%...

The Foreign Assets of Small Taxpayers–Disclosure Scheme was launched during the 2026–27 Union Budget.

Retail investors who spotted Seth Klarman buying Vaxcyte in May were already two months behind a trade Baupost had quietly begun unwinding. Understanding exactly what got lost in that gap changes how you should read every 13F going forward.

Willis Towers Watson's organic growth, specialty insurance expansion, AI-driven efficiencies and strong cash flow support earnings, while competition and softer rates remain risks.

PGR edges BRK.B on price gains, analyst sentiment and ROE, as both insurers lean on disciplined underwriting and strong fundamentals.

Insurance brokerages are benefiting from rising demand, M&A and digitization, with Willis Towers Watson, Aon, Gallagher and Brown & Brown in focus.

Brown & Brown's strong acquisition-led growth, rising commissions and fees, and cash generation support earnings, while debt and expenses weigh on margins.

Zacks Insurance Brokerage players like WTW, AJG, AON and BRO are likely to benefit from increased demand for insurance products, strategic acquisitions and the adoption of technology.

On Mad Money’s Monday episode, Jim Cramer pointed to Willis Towers Watson Public Limited Company (NASDAQ:WTW) as July’s fifth-best performer in the S&P 500. Noticing a rare rally in a typically quiet name, he commented: In fifth place was a company called Willis Towers Watson. I never talk about these guys. This is a major […]

The modeled fair value for Willis Towers Watson has shifted from US$334.32 to US$358.21, indicating a modestly higher central price target in the latest update. This move sits within a wide spread of analyst targets that reflect different views on catastrophe exposure, the insurance cycle, and how much execution risk is already built into the stock. As you read on, you will see how to interpret these shifting targets and keep track of the evolving Willis Towers Watson narrative. Analyst Price...